RDHL Stock Recent News
RDHL LATEST HEADLINES
RedHill Biopharma Ltd. (NASDAQ:RDHL ) Q1 2022 Results Conference Call June 23, 2022 8:30 AM ET Company Participants Debbie Bechor - Business Development & Communications Manager Dror Ben-Asher - Chief Executive Officer Rick Scruggs - President and Chief Commercial Officer Guy Goldberg - Chief Business Officer Gilead Raday - Chief Operating Officer Micha Ben-Chorin - Chief Financial Officer Adi Frish - Chief Corporate and Business Development Officer Rob Jackson - Senior Vice President of Marketing Conference Call Participants Brandon Folkes - Cantor Fitzgerald Boobalan Pachaiyappan - H.C.
RedHill Biopharma Ltd (NASDAQ: RDHL) plans announced a cost reduction plan expected to generate operational cost savings of approximately $50 million over the next 18 months. Most of these savings result from an approximately one-third reduction of the U.S. commercial team workforce,.
TEL AVIV, Israel and RALEIGH, N.C. , June 17, 2022 /PRNewswire/ -- RedHill Biopharma Ltd.